Literature DB >> 23953685

Clinical management of older persons with haemophilia.

C Hermans1, P de Moerloose2, G Dolan3.   

Abstract

Life expectancy for people with haemophilia (PWH) has improved and is now approaching that of the general population. The growing population of elderly PWH will therefore increasingly face the age-related morbidities such as cardiovascular diseases, malignant disease, liver disease, and bone and joint related diseases, as well as the lifestyle and psychosocial factors that accompany many of these conditions. For many PWH, frequent contact with haemophilia specialists within the comprehensive care centres supplants the relationship that individuals in the general population have with their general practitioners. As a result, there is a risk that elderly PWH may miss the chronic disease screening opportunities offered to the general population. This review focuses on the screening tests and examinations recommended for age-related comorbidities in the general population that may be applicable to the growing population of older people with haemophilia.
Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Ageing; Cancer; Cardiovascular disease; Comorbidity; Haemophilia

Mesh:

Year:  2013        PMID: 23953685     DOI: 10.1016/j.critrevonc.2013.07.005

Source DB:  PubMed          Journal:  Crit Rev Oncol Hematol        ISSN: 1040-8428            Impact factor:   6.312


  7 in total

1.  Tailoring care to haemophilia patients' needs: which specialty and when?

Authors:  Massimo Morfini; Gary Benson; Victor Jiménez-Yuste; Rolf Ljung; Pier Mannuccio Mannucci; Gianluigi Pasta; Eduardo Remor; Silva Zupančić Šalek
Journal:  Blood Transfus       Date:  2015-05-20       Impact factor: 3.443

Review 2.  Management of Hemophilia in Older Patients.

Authors:  Massimo Franchini; Pier Mannuccio Mannucci
Journal:  Drugs Aging       Date:  2017-12       Impact factor: 3.923

Review 3.  Osteoporosis management and falls prevention in patients with haemophilia: Review of haemophilia guidelines.

Authors:  Madison J Petkovic; Huyen A Tran; Peter R Ebeling; Ayse Zengin
Journal:  Haemophilia       Date:  2022-03-15       Impact factor: 4.263

Review 4.  Factor VIII replacement prophylaxis in patients with hemophilia A transitioning to adults: a systematic literature review.

Authors:  Jing Sun; Xuan Zhou; Nan Hu
Journal:  Orphanet J Rare Dis       Date:  2021-06-26       Impact factor: 4.123

5.  Mild hemophilia A presaged by recurrent postoperative hemorrhagic complications in an elderly patient.

Authors:  Hajime Ono; Taigen Sase; Hiroshi Takasuna; Yuichiro Tanaka
Journal:  Surg Neurol Int       Date:  2017-09-06

6.  BAY 81-8973 demonstrated efficacy, safety and joint status improvement in patients with severe haemophilia A in the LEOPOLD I extension for ≤2 years.

Authors:  Johnny Mahlangu; Maria Fernanda Lopez Fernandez; Elena Santagostino; Shadan Lalezari; Despina Tseneklidou-Stoeter; Horst Beckmann; Nikki Church
Journal:  Eur J Haematol       Date:  2020-03-23       Impact factor: 2.997

7.  Deletion of Coagulation Factor IX Compromises Bone Mass and Strength: Murine Model of Hemophilia B (Christmas Disease).

Authors:  Emily A Larson; Hillary J Larson; Jason A Taylor; Robert F Klein
Journal:  Calcif Tissue Int       Date:  2021-06-12       Impact factor: 4.333

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.